Dorsey Brian

Track

Insider profile

Performance

Overall performance
1.9
Performance over holding periods
1.9
30 days 90 days 120 days
Average return -3% 8.2% 15.1%
Success rate 62% 68% 82%
Transactions
2 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Dorsey Brian's trades of ARS Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
184.91
Quantity 42,851
Value US$1,532,789
Transaction date
Proposed sale
Price
13.31
Quantity 61,200
Value US$814,572
Transaction date
Proposed sale
Price
15.00
Quantity 50,000
Value US$750,000
Transaction date
Proposed sale
Price
13.00
Quantity 30,000
Value US$390,000
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-11-14 2025-11-13
S Sale
54,856 +36.8%
497.79
US$521,816 		54,856 +36.8% 497.79 US$521,816
2025-11-13 2025-11-13
PrS Proposed sale
42,851
184.91
US$1,532,789 		42,851 184.91 US$1,532,789
2024-12-13 2024-12-12
S Sale
8,475 +29.1%
491.63
US$3,434,771 		8,475 +29.1% 491.63 US$3,434,771
2024-12-13 2024-12-11
PlS Planned sale
15,000 -71.3%
12.43
US$186,426 		15,000 -71.3% 12.43 US$186,426
2024-12-11 2024-12-11
PrS Proposed sale
61,200
13.31
US$814,572 		61,200 13.31 US$814,572
2024-08-21 2024-08-20
PlS Planned sale
50,000 -89.2%
15.00
US$750,000 		50,000 -89.2% 15.00 US$750,000
2024-08-20 2024-08-20
PrS Proposed sale
50,000
15.00
US$750,000 		50,000 15.00 US$750,000
2024-08-15 2024-08-13
PlS Planned sale
30,000 -83.3%
13.00
US$390,000 		30,000 -83.3% 13.00 US$390,000
2024-08-13 2024-08-13
PrS Proposed sale
30,000
13.00
US$390,000 		30,000 13.00 US$390,000